A Study to Assess S-309309 in Healthy and Obese Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The primary aim of the study is to assess the safety and tolerability of S-309309 after oral administration in healthy adult or obese but otherwise healthy adult participants. The secondary aim of the study is to assess the pharmacokinetics of S-309309 and the effects on ECG parameters after oral administration in healthy or obese but otherwise healthy participants.
Epistemonikos ID: 934ffaba47d7a14bb802acb7177144f4336f080b
First added on: May 10, 2024